The T1D Fund Team - T1D Fund: A Breakthrough T1D Venture

Steven St. Peter Managing Director

Sylvia Tobé Managing Director

Eric Shen Chief of Staff

Sean O'Connor Principal

Clay Rowland Associate

Valerie Su Associate

Morgan Janes Associate

Yash Malliwal Analyst

Matt Williams Director of Operations

Tim Clark, Chair

Aaron J. Kowalski

Steven St. Peter, Chair Managing Director

Sean Doherty Founder & Senior Advisor

Bruce Buckingham, M.D. Professor, Department of Pediatrics, Endocrinology and Diabetes Division, Stanford University School of Medicine

Colin Dayan, M.A. M.B.B.S., F.R.C.P., Ph.D. Professor of Clinical Diabetes and Metabolism, Cardiff University School of Medicine Professor of Endocrinology and Diabetes, University of Bristol

Steve Engen CEO, Renexes LLC

Carmella Evans-Molina, M.D., Ph.D. J.O. Ritchey Scholar Professor of Medicine, Indiana University School of Medicine

Peter Gottlieb, M.D. Professor of Pediatrics and Medicine at the Barbara Davis Center at the University of Colorado School of Medicine.

Francine Kaufman, M.D. Chief Medical Officer, Senseonics

Robert Langer, Sc.D. David H. Koch Institute Professor, MIT

Frank Martin, Ph. D. Partner Caladrius Ventures

Chantal Mathieu, M.D., Ph.D. Katholieke Universiteit Leuven, Belgium

Douglas Melton, Ph.D. Harvard Department of Stem Cell and Regenerative Biology, Howard Hughes Medical Institute

Jennifer Sherr, M.D., Ph.D. Associate Professor, Pediatrics, Yale University School of Medicine